10 Stocks on Jim Cramer’s Radar

7. GSK plc (NYSE:GSK)

Number of Hedge Fund Holders: 38

A caller asked if they should buy GSK plc (NYSE:GSK) and Cramer said:

“Well, look, GSK is a very inexpensive stock with a 4% yield, with a lot of things going for it. I’m gonna say yes to that.”

GSK (NYSE:GSK) focuses on researching, developing, and producing vaccines, along with specialty and general medicines designed to prevent and treat a range of diseases. Over the past 12 months, GSK stock declined more than 11%. Furthermore, Cramer was asked about the company in October 2024 once it settled its lawsuits over its drug Zantac, and he said:

“Yeah, that was huge. I’ve been waiting for that. I was hoping for that. They got the settlements behind them. Now we’re moving on. GSK goes higher.”